Stephen Tsang, MD, PhD

Professor at Columbia University and attending physician at NewYork-Presbyterian Hospital

Articles by Stephen Tsang, MD, PhD

Q&A: Stephen Tsang discusses outcomes in retinitis pigmentosa and Stargardt trials

ByStephen Tsang, MD, PhD,Sheryl Stevenson

November 10th 2025

Stephen Tsang, MD, PhD, reviews promising optogenetic therapy results for retinitis pigmentosa and Stargardt disease, enhancing vision and mobility for patients.

Stephen Tsang, MD, PhD

Articles by Stephen Tsang, MD, PhD

Q&A: Stephen Tsang discusses outcomes in retinitis pigmentosa and Stargardt trials

Latest Updated Articles

Trending on Ophthalmology Times Europe

Q&A: Stephen Tsang discusses outcomes in retinitis pigmentosa and Stargardt trials

Q&A: Diana Do shares real world insights on aflibercept 8 mg